CA2373336A1 - Peroxynitrite decomposition catalysts and methods of use thereof - Google Patents
Peroxynitrite decomposition catalysts and methods of use thereof Download PDFInfo
- Publication number
- CA2373336A1 CA2373336A1 CA002373336A CA2373336A CA2373336A1 CA 2373336 A1 CA2373336 A1 CA 2373336A1 CA 002373336 A CA002373336 A CA 002373336A CA 2373336 A CA2373336 A CA 2373336A CA 2373336 A1 CA2373336 A1 CA 2373336A1
- Authority
- CA
- Canada
- Prior art keywords
- complex
- formula
- moiety
- peroxynitrite
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic System
- C07F13/005—Compounds without a metal-carbon linkage
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
- C07F15/02—Iron compounds
- C07F15/025—Iron compounds without a metal-carbon linkage
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
- C07F15/04—Nickel compounds
- C07F15/045—Nickel compounds without a metal-carbon linkage
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/005—Compounds of elements of Group 5 of the Periodic System without metal-carbon linkages
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13730899P | 1999-06-03 | 1999-06-03 | |
US60/137,308 | 1999-06-03 | ||
US09/587,382 US6448239B1 (en) | 1999-06-03 | 2000-06-01 | Peroxynitrite decomposition catalysts and methods of use thereof |
US09/587,382 | 2000-06-01 | ||
PCT/US2000/015269 WO2000075144A2 (en) | 1999-06-03 | 2000-06-02 | Peroxynitrite decomposition catalysts and methods of use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2373336A1 true CA2373336A1 (en) | 2000-12-14 |
Family
ID=26835128
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002373336A Abandoned CA2373336A1 (en) | 1999-06-03 | 2000-06-02 | Peroxynitrite decomposition catalysts and methods of use thereof |
Country Status (6)
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7432369B2 (en) | 2004-03-29 | 2008-10-07 | Inotek Pharmaceuticals Corporation | Pyridyl-substituted porphyrin compounds and methods of use thereof |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5747026A (en) * | 1993-10-15 | 1998-05-05 | University Of Alabama At Birmingham Research Foundation | Antioxidants |
ATE312103T1 (de) | 1999-01-25 | 2005-12-15 | Nat Jewish Med & Res Center | Substituierte porphyrine und deren therapeutische verwendungen |
US6448239B1 (en) * | 1999-06-03 | 2002-09-10 | Trustees Of Princeton University | Peroxynitrite decomposition catalysts and methods of use thereof |
US6403788B1 (en) | 2000-07-11 | 2002-06-11 | Eukarion, Inc. | Non-genotoxic metalloporphyrins as synthetic catalytic scavengers of reactive oxygen species |
GB0029562D0 (en) | 2000-12-04 | 2001-01-17 | Novartis Ag | Organic compounds |
US20020072512A1 (en) * | 2000-12-08 | 2002-06-13 | Metaphore Pharmaceuticals, Inc | Method of preventing and treating HIV-mediated central nervous system damage |
US20040137638A1 (en) * | 2002-03-04 | 2004-07-15 | Slomczynska Urszula J. | Chromatography of metal complexes |
JP2005508864A (ja) | 2001-06-01 | 2005-04-07 | ナショナル・ジュウィッシュ・メディカル・アンド・リサーチ・センター | 糖尿病の治療、または移植術における使用、または免疫寛容の誘導のためのオキシダントスカベンジャー |
DE10240343A1 (de) * | 2002-08-27 | 2004-03-11 | Schering Ag | Peroxynitrit-Umlagerungskatalysatoren |
US20040127479A1 (en) * | 2002-08-27 | 2004-07-01 | Merck Patent Gmbh | Peroxynitrite rearrangement catalysts |
GB2397067B (en) * | 2002-12-23 | 2005-05-11 | Destiny Pharma Ltd | Porphin & azaporphin derivatives with at least one cationic-nitrogen-containing meso-substituent for use in photodynamic therapy & in vitro sterilisation |
US20050025804A1 (en) * | 2003-07-28 | 2005-02-03 | Adam Heller | Reduction of adverse inflammation |
US7299082B2 (en) | 2003-10-31 | 2007-11-20 | Abbott Diabetes Care, Inc. | Method of calibrating an analyte-measurement device, and associated methods, devices and systems |
US7699964B2 (en) | 2004-02-09 | 2010-04-20 | Abbott Diabetes Care Inc. | Membrane suitable for use in an analyte sensor, analyte sensor, and associated method |
US8165651B2 (en) | 2004-02-09 | 2012-04-24 | Abbott Diabetes Care Inc. | Analyte sensor, and associated system and method employing a catalytic agent |
EP1718201B1 (en) * | 2004-02-09 | 2016-09-14 | Duke University | Substituted porphyrins |
GB2415372A (en) | 2004-06-23 | 2005-12-28 | Destiny Pharma Ltd | Non photodynamical or sonodynamical antimicrobial use of porphyrins and azaporphyrins containing at least one cationic-nitrogen-containing substituent |
CA2595236A1 (en) * | 2005-01-19 | 2006-07-27 | Pharmacyclics, Inc. | A method for treating neurologic diseases |
JP2006224318A (ja) * | 2005-02-15 | 2006-08-31 | Brother Ind Ltd | インクジェット記録装置 |
EP1928467A4 (en) | 2005-09-28 | 2009-11-04 | Inotek Pharmaceuticals Corp | N-BENZYL SUBSTITUTED PORPHYRIN PYRIDYL COMPOUNDS AND METHODS OF USE |
US7885698B2 (en) | 2006-02-28 | 2011-02-08 | Abbott Diabetes Care Inc. | Method and system for providing continuous calibration of implantable analyte sensors |
WO2008094222A2 (en) * | 2006-10-06 | 2008-08-07 | Trustees Of Princeton | Porphyrin catalysts and methods of use thereof |
WO2008045358A1 (en) * | 2006-10-06 | 2008-04-17 | Trustees Of Princeton | Porphyrin catalysts and methods of use thereof |
SI2056675T1 (sl) | 2006-10-12 | 2019-08-30 | Galera Labs, Llc | Postopki za zdravljenje oralnega mukozitisa |
AU2008293376B2 (en) * | 2007-08-28 | 2013-07-11 | Technion Research & Development Foundation Ltd. | Transition metal complexes of corroles for preventing cardiovascular diseases or disorders |
WO2009059271A1 (en) * | 2007-11-02 | 2009-05-07 | University Of Miami | Diagnosis and treatment of cardiac disorders |
JP5608644B2 (ja) | 2008-05-23 | 2014-10-15 | ナショナル ジューイッシュ ヘルス | アルキル化種の被爆に関連する損傷の処置方法 |
US20120065181A1 (en) * | 2009-05-26 | 2012-03-15 | Warner David S | Method of providing neuroprotection using substituted porphyrins |
US20120135973A1 (en) * | 2010-09-08 | 2012-05-31 | Southern Illinois University Edwardsville | Method for treating chronic pain |
JP5823988B2 (ja) * | 2011-01-31 | 2015-11-25 | 国立大学法人宇都宮大学 | ポルフィリン型骨格を有する化合物の金属錯体の製造方法 |
US20140227184A1 (en) | 2011-08-19 | 2014-08-14 | The Trustees Of Princeton University | C-halogen bond formation |
CN103906756B (zh) | 2011-09-26 | 2020-03-03 | 加莱拉实验室有限责任公司 | 用于治疗疾病的方法 |
WO2014064697A1 (en) * | 2012-10-25 | 2014-05-01 | Technion Research And Development Foundation Ltd. | Method of treatment of disease |
JP2016509016A (ja) | 2013-02-13 | 2016-03-24 | カリフォルニア インスティチュート オブ テクノロジー | 金属酸化物のスルホン酸エステル及びその使用の方法 |
JP6154231B2 (ja) * | 2013-07-22 | 2017-06-28 | 学校法人同志社 | 抗癌剤 |
US20160264512A1 (en) | 2013-10-09 | 2016-09-15 | The Trustees Of Princeton University | C-halogen bond formation |
CA2933166C (en) | 2013-12-31 | 2020-10-27 | Abbott Diabetes Care Inc. | Self-powered analyte sensor and devices using the same |
EP3094356A4 (en) * | 2014-01-17 | 2017-06-14 | California Institute of Technology | Sulfonic esters of metal oxides and methods of their use |
WO2015153863A1 (en) * | 2014-04-03 | 2015-10-08 | John Wayne Kennedy | Copper/zinc superoxide dismutase (sod) formulation for the treatment of traumas including amyotropic lateral sclerosis |
US9364537B2 (en) | 2014-08-22 | 2016-06-14 | University Of Dayton | Transition metal porphyrin complexes and methods of treatment using same |
RS60558B1 (sr) | 2015-08-11 | 2020-08-31 | Galera Labs Llc | Pentaaza makrociklični prstenasti kompleksi koji poseduju oralnu bioraspoloživost |
KR20190130654A (ko) | 2017-04-04 | 2019-11-22 | 바이오미매틱스 제이브이, 엘엘씨 | 방사선 요법 및/또는 화학요법 노출과 연관된 부작용의 치료 및/또는 예방을 위한 방법, 조성물, 및 키트 |
US11246950B2 (en) | 2017-04-13 | 2022-02-15 | Galera Labs, Llc | Combination cancer immunotherapy with pentaaza macrocyclic ring complex |
US11344574B2 (en) | 2017-09-29 | 2022-05-31 | Duke University | Fluoro substituted porphyrin compounds, pharmaceutical compositions comprising the same, and methods of preparing and using the same |
CN107936030A (zh) * | 2017-11-21 | 2018-04-20 | 西北民族大学 | 水溶性含溴铜卟啉及其溴取代衍生物、其合成方法和应用 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5284647A (en) | 1988-03-18 | 1994-02-08 | Schering Aktiengesellschaft | Mesotetraphenylporphyrin complex compounds, process for their production and pharmaceutical agents containing them |
US5109016A (en) | 1988-05-23 | 1992-04-28 | Georgia State University Foundation, Inc. | Method for inhibiting infection or replication of human immunodeficiency virus with porphyrin and phthalocyanine antiviral compositions |
US5457183A (en) * | 1989-03-06 | 1995-10-10 | Board Of Regents, The University Of Texas System | Hydroxylated texaphyrins |
US5637739A (en) * | 1990-03-21 | 1997-06-10 | Research Corporation Technologies, Inc. | Chiral catalysts and catalytic epoxidation catalyzed thereby |
DE69224839T2 (de) | 1991-07-19 | 1998-10-08 | Monsanto Co | Mangan-Komplexe mit Stickstoff enthaltenden makrozyklischen Liganden, wirksam als Superoxiddismutasekatalysatoren. |
US5296466A (en) | 1992-02-19 | 1994-03-22 | Board Of Regents, The University Of Texas System | Inhibition of nitric oxide-mediated hypotension and septic shock with iron-containing hemoprotein |
JPH10500671A (ja) | 1994-05-13 | 1998-01-20 | モンサント カンパニー | ペルオキシ亜硝酸塩分解触媒の使用方法、そのための薬剤組成物 |
US6245758B1 (en) | 1994-05-13 | 2001-06-12 | Michael K. Stern | Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor |
WO1996009053A1 (en) | 1994-09-20 | 1996-03-28 | Duke University | Oxidoreductase activity of manganic porphyrins |
UA58494C2 (uk) | 1995-06-07 | 2003-08-15 | Зенека Лімітед | Похідні n-гетероарилпіридинсульфонаміду, фармацевтична композиція, спосіб одержання та спосіб протидії впливам ендотеліну |
US6002026A (en) | 1996-07-26 | 1999-12-14 | The Trustees Of Princeton University | Catalytic oxygenation of hydrocarbons by metalloporphyrin and metallosalen complexes |
EP0988037A1 (en) * | 1997-02-05 | 2000-03-29 | Board Of Regents, The University Of Texas System | Porphyrin compounds as telomerase inhibitors |
US6121278A (en) | 1997-09-03 | 2000-09-19 | Guilford Pharmaceuticals, Inc. | Di-n-heterocyclic compounds, methods, and compositions for inhibiting parp activity |
US6448239B1 (en) * | 1999-06-03 | 2002-09-10 | Trustees Of Princeton University | Peroxynitrite decomposition catalysts and methods of use thereof |
-
2000
- 2000-06-01 US US09/587,382 patent/US6448239B1/en not_active Expired - Fee Related
- 2000-06-02 CA CA002373336A patent/CA2373336A1/en not_active Abandoned
- 2000-06-02 JP JP2001502426A patent/JP2003501432A/ja not_active Withdrawn
- 2000-06-02 AU AU54603/00A patent/AU780118B2/en not_active Expired - Fee Related
- 2000-06-02 EP EP00939526A patent/EP1185532A1/en not_active Withdrawn
- 2000-06-02 WO PCT/US2000/015269 patent/WO2000075144A2/en not_active Application Discontinuation
-
2002
- 2002-07-29 US US10/207,323 patent/US6969707B2/en not_active Expired - Fee Related
-
2005
- 2005-11-10 US US11/270,974 patent/US20060199792A1/en not_active Abandoned
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7432369B2 (en) | 2004-03-29 | 2008-10-07 | Inotek Pharmaceuticals Corporation | Pyridyl-substituted porphyrin compounds and methods of use thereof |
Also Published As
Publication number | Publication date |
---|---|
WO2000075144A2 (en) | 2000-12-14 |
US6969707B2 (en) | 2005-11-29 |
US6448239B1 (en) | 2002-09-10 |
EP1185532A1 (en) | 2002-03-13 |
WO2000075144A3 (en) | 2001-06-28 |
US20030055032A1 (en) | 2003-03-20 |
WO2000075144A9 (en) | 2002-07-11 |
AU5460300A (en) | 2000-12-28 |
AU780118B2 (en) | 2005-03-03 |
US20060199792A1 (en) | 2006-09-07 |
WO2000075144A8 (en) | 2001-08-09 |
JP2003501432A (ja) | 2003-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6448239B1 (en) | Peroxynitrite decomposition catalysts and methods of use thereof | |
US8334377B2 (en) | Porphyrin catalysts and methods of use thereof | |
US8232267B2 (en) | Porphyrin catalysts and methods of use thereof | |
EP1212323B1 (en) | Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity | |
EP1301515B1 (en) | Non-genotoxic metalloporphyrins as synthetic catalytic scavengers of reactive oxygen species | |
EP1718201B1 (en) | Substituted porphyrins | |
CA2224060C (en) | Manganese or iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide | |
WO1994015925A1 (en) | Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide | |
MXPA06011244A (es) | Compuestos de porfirina sustituida por piridilo, y metodos de uso de los mismos. | |
US6376664B1 (en) | Cyclic bis-benzimidazole ligands and metal complexes thereof | |
Lin et al. | Crystal structure and superoxide dismutase activity of a six-coordinate manganese (III) complex | |
US7649091B2 (en) | Orally bioavailable low molecular weight metalloporphyrins as antioxidants | |
CZ277698A3 (cs) | Komplexy železa makrocyklických ligandů obsahujících dusík, působící jako katalyzátory pro dismutaci superoxidu | |
Tibrewala | New water soluble pyridyl porphyrins for use as peroxynitrite decomposition catalysts and heme model compounds | |
WO1997023489A1 (en) | High oxidation state metal oxo complexes of the phab ligand | |
James | Manganese complexes with biomimetic antioxidant activity | |
Norin | Coordination Chemistry of Novel Drug Candidates for the Treatment of Iron Overload | |
MXPA98007449A (en) | Complexes with iron of macrocyclic ligands containing nitrogen, effective as catalysts to dismute superox |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |